de la Haba-Rodriguez, Juan <br/><br/>
Exemestane and chemotherapy as first-line treatment of metastatic breast cancer: results of a phase II study.  [electronic resource] 

 -  Clinical breast cancer  Aug 2010 
 - 313-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial, Phase II; Journal Article; Multicenter Study; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1938-0666 
<br/><br/><label>Standard No.: </label>10.3816/CBC.2010.n.041  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Aged<br/>Androstadienes--therapeutic use<br/>Antineoplastic Combined Chemotherapy Protocols--therapeutic use<br/>Aromatase Inhibitors--therapeutic use<br/>Breast Neoplasms--drug therapy<br/>Cyclophosphamide--administration & dosage<br/>Disease-Free Survival<br/>Epirubicin--administration & dosage<br/>Female<br/>Fluorouracil--administration & dosage<br/>Humans<br/>Kaplan-Meier Estimate<br/>Middle Aged<br/>Postmenopause<br/>Treatment Outcome